Deferasirox

In the US, Deferasirox (deferasirox systemic) is a member of the drug class chelating agents and is used to treat Hemosiderosis.

US matches:

• Deferasirox

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V03AC03

CAS registry number (Chemical Abstracts Service)

0201530-41-8

Chemical Formula

C21-H15-N3-O4

Molecular Weight

373

Therapeutic Categories

Chelating agent

iron chelator

Chemical Names

4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl}benzoesäure (IUPAC)

4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl}benzoic acid (WHO)

Foreign Names

• Deferasiroxum (Latin)
• Deferasirox (German)
• Deferasirox (French)
• Deferasirox (Spanish)

Generic Names

• Deferasirox (OS: USAN)
• CGP-72670 (IS: Novartis)
• ICL 670 (IS)
• ICL-670A (IS: Novartis)

Brand Names

• Exjade
  Novartis, Argentina; Novartis, Australia; Novartis, Belgium; Novartis, Bulgaria; Novartis, Canada; Novartis, Switzerland; Novartis, Germany; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Italy; Novartis, Mexico; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, Venezuela; Novartis, South Africa; Novartis Europharm, Austria; Novartis Europharm Ltd., Denmark; Novartis Pharmaceuticals, Peru

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.